UNSPSC 51461530: Black cohosh

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K73E24S6X9 and which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 821148 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivis ion Angiospermae, Class Magnoliopsida, Superorder Ranunculanae, Order Ranunculales, Family Ranunculaceae, Genus Actaea L. (baneberry) Species Actaea racemosa L., more commonly known as BLACK BANEBERRY, BLACK SNAKEROOT, or as here, BLACK COHOSH.

UNSPSC 51461530 Black cohosh is a Commodity code capturing botanical dietary supplements and herbal products purchased by state and local health systems, purchasing cooperatives, and institutional pharmacies. State and local governments procure black cohosh and related herbal remedies primarily through multi-source pharmaceutical cooperative contracts that bundle botanical products with conventional OTC medications and generic pharmaceuticals. The buying bodies are typically state agencies administering cooperative purchasing alliances, regional health systems, and participating local government facilities that leverage these agreements to consolidate procurement and reduce costs through volume pricing and established wholesaler relationships.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products including herbal supplements, with proposals due March 26, 2026. Vendors must supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and certify cGMP compliance and DSCSA certification. Products must be available by May 15, 2026, with resulting agreements effective July 1, 2026 and extending two years for new responders, with optional extensions at MMCAP's discretion. Evaluation weights pricing at 75 percent, with smaller weightings for administrative fee compliance, EDI capability, and pricing format flexibility; vendors must maintain $5 million commercial general liability coverage and accept a 3 percent administrative fee on all contract purchases. The RFP does not identify set-aside restrictions, and MMCAP reserves the right to make sole, dual, or multi-awards based on therapeutic considerations and member-specific needs.